GemCyclo Bio
Leading the Era of Oral Cyclic Peptides
Active
Pre-Funding
Startup
Jerusalem
Founded 2025-03
GemCyclo Bio is an early-stage bio-pharmaceutical company holding a library of novel orally available cyclic peptides targeting validated molecular pathways of immune and inflammatory diseases (I&I), Cancer, and metabolic diseases. The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed and synthesized by Prof Chaim Gilon…
SectorHealth Tech & Life Sciences
StagePre-Funding
Employees5
Founded2025-03
HQJerusalem
Confidence75
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals